55.3
Dare Bioscience, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
43.0
FY23:
17.5
FY24:
18.4
FY25:
27.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.51
FY22:
0.79
FY23:
3.74
FY24:
3.65
FY25:
5.41
Total assets
Change from FY21 to FY25
millions USD
FY21:
55.8
FY22:
43.8
FY23:
21.3
FY24:
22.1
FY25:
32.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.1
FY22:
31.6
FY23:
20.5
FY24:
21.6
FY25:
23.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.00
FY22:
1.09
FY23:
5.85
FY24:
6.50
FY25:
5.95
(positive)
Change from FY21 to FY25
millions USD
FY21:
38.8
FY22:
11.1
FY23:
−5.05
FY24:
−6.01
FY25:
2.84
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
55.8
FY22:
43.8
FY23:
21.3
FY24:
22.1
FY25:
32.5
All amounts in millions USD